Amy Franke
Hoofd Techniek/Wetenschap/O&O bij SHATTUCK LABS, INC.
Profiel
Amy Franke is currently the Vice President-Clinical Operations at Shattuck Labs, Inc. She previously worked as the Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Ms. Franke completed her undergraduate degree at the University of Michigan and her graduate degree at the University of Pennsylvania Medical Center.
Actieve functies van Amy Franke
| Bedrijven | Functie | Begin |
|---|---|---|
| SHATTUCK LABS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2022 |
Eerdere bekende functies van Amy Franke
| Bedrijven | Functie | Einde |
|---|---|---|
| ARAVIVE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2022 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Amy Franke
| University of Pennsylvania Medical Center | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
